Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Director Dealing

7 Dec 2020 11:25

RNS Number : 7775H
IQ-AI Limited
07 December 2020
 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 

 

IQ-AI Ltd(the "Company")

 

Director Dealing

 

The Company has been notified that Trevor Brown, CEO of the Company, has sold 5,166,667 ordinary shares in the Company indirectly via Free Association Books and directly in his own name. 

 

Following this transaction, Trevor Brown continues to hold 42,360,736 ordinary shares in the Company, representing approximately 26.39 per cent. of the Company's issued ordinary share capital. In addition, Mr Brown continues to hold £50,000 convertible loan notes convertible at 2p and £250,000 convertible loan notes convertible at 1.5p.

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

-ENDS-

For further information, please contact:

IQ-AI Limited

Trevor Brown/Vinod Kaushal/Qu Li

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Persons Closely Associated with them

This notification relates to transactions notified in accordance with the Market Abuse Regulation, further details below:

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Trevor Brown

2.

Reason for the notification

a)

Position/status

Director

b)

Initial notification/ Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 IQ-AI Limited

b)

LEI

213800SPW48XRJS2QH57

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary share JE00BD4H0R42

b)

Nature of the transaction

Converted loan to new shares

 c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.10

0.10

0.10

2,416,667

2,250,000

500,000

d)

Aggregated information

· Aggregated volume

· Price

 

5,166,667

0.10

e)

Date of the transaction

3 and 4 December 2020

f)

Place of the transaction

London Stock Exchange Main Market

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAFAXEADEFFA
Date   Source Headline
1st Jun 20207:00 amRNSIB Awarded $2.57m grant
19th May 20209:19 amRNSNotice of AGM
4th May 202010:04 amRNSFinal Results
30th Apr 20201:08 pmRNSDelay in Publishing Final Year Accounts
18th Mar 20202:34 pmRNSIB's Software featured in award-winning article
3rd Mar 20204:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20204:35 pmRNSPrice Monitoring Extension
28th Feb 20201:42 pmRNSTotal Voting Rights
5th Feb 20204:30 pmRNSConversion of Loan Notes - Correction
5th Feb 20203:20 pmRNSConversion of Loan Notes
27th Jan 20209:29 amRNSImaging Biometrics Adds to Development Team
20th Jan 20207:00 amRNSKFDA Clearance for StoneChecker Software
13th Jan 202011:35 amRNSExercise of Options
9th Jan 20207:00 amRNSImaging Biometrics Partners with AI Metrics
18th Dec 201912:46 pmRNSBoard Changes and Restructuring Initiatives
7th Nov 20197:01 amRNSInitiation of IB Stroke Project
2nd Oct 20192:00 pmRNSPrice Monitoring Extension
1st Oct 20192:05 pmRNSSecond Price Monitoring Extn
1st Oct 20192:00 pmRNSPrice Monitoring Extension
1st Oct 201911:05 amRNSSecond Price Monitoring Extn
1st Oct 201911:00 amRNSPrice Monitoring Extension
1st Oct 20199:05 amRNSSecond Price Monitoring Extn
1st Oct 20199:00 amRNSPrice Monitoring Extension
1st Oct 20197:01 amRNSStoneChecker USA Market Introduction
1st Oct 20197:00 amRNSIssue of Equity
30th Sep 201911:05 amRNSSecond Price Monitoring Extn
30th Sep 201911:00 amRNSPrice Monitoring Extension
27th Sep 20197:00 amRNSFDA Clearance to Market for StoneChecker Software
16th Sep 20199:34 amRNSReplacement - Half Yearly Report to 30 June 2019
16th Sep 20197:00 amRNSHalf-year Report
4th Sep 20197:00 amRNSGrant Award
6th Aug 20197:00 amRNSCompletion of Placing and Conversion of Loan Notes
5th Aug 20192:05 pmRNSSecond Price Monitoring Extn
5th Aug 20192:00 pmRNSPrice Monitoring Extension
9th Jul 20197:00 amRNSUpdate on Gadolinium Free Imaging Project
26th Jun 20197:00 amRNSPlacing
24th Jun 20192:52 pmRNSHolding(s) in Company
20th Jun 20194:40 pmRNSSecond Price Monitoring Extn
20th Jun 20194:35 pmRNSPrice Monitoring Extension
12th Jun 20197:00 amRNSBusiness Development Agreement with CorTechs Labs
6th Jun 201911:49 amRNSResult of AGM
29th May 201911:51 amRNSIssue of Convertible Loan Notes - Correction
29th May 20198:22 amRNSIssue of Convertible Loan Notes
17th May 201912:00 pmRNSExtension of Loan Notes Redemption Date
9th May 20191:30 pmRNSNotice of AGM
9th May 201912:13 pmRNSHolding(s) in Company
30th Apr 201912:00 pmRNSPublication of Annual Report
2nd Apr 20197:00 amRNSImaging Biometrics Update
11th Mar 20197:00 amRNSIssue of Convertible Loan Notes
8th Feb 201910:29 amRNSBusiness Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.